An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. Researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) report their results today (Feb. 26) at the 2008 ASM Biodefense and Emerging Diseases Research Meeting in Baltimore, MD.

A collaborative team of scientists reported findings today demonstrating the presence of Marburg virus RNA genome and antibodies in a common species of African fruit bat (Rousettus aegyptiacus).